CN202434108U - Chemical model of 4-((3-methylene pyridine)-amino)-6-methyl-4, 5-dihydro-2H-(1, 2, 4) triazole-3-ketone - Google Patents
Chemical model of 4-((3-methylene pyridine)-amino)-6-methyl-4, 5-dihydro-2H-(1, 2, 4) triazole-3-ketone Download PDFInfo
- Publication number
- CN202434108U CN202434108U CN2011205566915U CN201120556691U CN202434108U CN 202434108 U CN202434108 U CN 202434108U CN 2011205566915 U CN2011205566915 U CN 2011205566915U CN 201120556691 U CN201120556691 U CN 201120556691U CN 202434108 U CN202434108 U CN 202434108U
- Authority
- CN
- China
- Prior art keywords
- model
- chemical
- pymetrozine
- ketone
- pyrrole aphid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The utility model relates to a chemical model of 4-((3-methylene pyridine)-amino)-6-methyl-4, 5-dihydro-2H-(1, 2, 4) triazole-3-ketone, which is a model built according to the molecular structure of pymetrozine, wherein the chemical model of the pymetrozine comprises a plurality of spheres representing atoms and a plurality of connecting rods representing chemical bonds, the chemical model of the pymetrozine consists of two molecules of the pymetrozine, i.e. the chemical model of the pymetrozine comprises two parts, each part is an independent pymetrozine molecular structure, and the connection of the two parts represents dimolecular weak bond connection by one of the plurality of connecting rods. The chemical model has the advantages that the chemical model can more preferably disclose the specific mode of the pymetrozine in the organism in the aspect of medicine effect playing, the acting force among the molecules is the key considered object, and the basis of the unique function of the pymetrozine is obtained by a dimolecular model, so that the technical support is provided for the follow-up synthesis of the compounds.
Description
Technical field
The utility model relates to model, relates in particular to a kind of 4-[(3-methylene pyridine)-amino]-6-methyl-4, the chemical model of 5-dihydro-2H-[1,2,4] triazole-3-ketone (being pyrrole aphid ketone).
Background technology
4-[(3-methylene pyridine)-amino]-6-methyl-4; 5-dihydro-2H-[1,2,4] triazole-3-ketone is the chemical name of higher effective and lower toxic pesticide pyrrole aphid ketone; This compound has unique pharmacological characteristic, has only pyrrole aphid ketone to have drug activity well in this compounds.Pyrrole aphid ketone specifically be how to bring into play drug effect be always research focus.We start with through the rock-steady structure model that makes up pyrrole aphid ketone, thereby disclose pyrrole aphid ketone specifically is how to bring into play drug effect in vivo, and intermolecular force is the object that our emphasis is considered.Yet existing theoretical majority is based upon on the unimolecule structural model, and this model structure rigidity is big, instability.
The utility model content
In view of this, be necessary to provide a kind of model structure rigidity less, can explain 4-[(3-methylene pyridine)-amino]-6-methyl-4 of the true rock-steady structure of pyrrole aphid ketone, the chemical model of 5-dihydro-2H-[1,2,4] triazole-3-ketone.
The utility model is achieved in that 4-[(3-methylene pyridine)-amino]-6-methyl-4,5-dihydro-2H-[1,2; 4] chemical model of triazole-3-ketone; Its model for making up according to pyrrole aphid ketone molecular structure, the chemical model of said pyrrole aphid ketone comprises some spheroids of representing atom and some connecting links of representing chemical bond, wherein; The chemical model of said pyrrole aphid ketone is made up of two molecules of pyrrole aphid ketone; The chemical model that is said pyrrole aphid ketone comprises two parts, and each part all is an independently pyrrole aphid ketone molecular structure, and on behalf of the bimolecular weak bond, two-part link connect through one in said some connecting links.
Compared with prior art; The 4-that the utility model provides [(3-methylene pyridine)-amino]-6-methyl-4,5-dihydro-2H-[1,2; 4] chemical model of triazole-3-ketone; Two molecules by pyrrole aphid ketone constitute, and each part all is an independently pyrrole aphid ketone molecular structure, link two-part connecting link and have represented the lone pair electrons of pyridine and the hydrogen bond between the hydrogen atom on the nitrogen-atoms on the triazine ring on the pyridine ring; This hydrogen bond action makes that pyrrole aphid ketone molecule is more stable; It specifically is how to bring into play drug effect in vivo that such chemical model is more conducive to disclose pyrrole aphid ketone, and intermolecular force is the object that our emphasis is considered, the molecular structure under bimolecular and even the polymolecular weak key action is only the key that pyrrole aphid ketone can be brought into play unique drug effect; Utilize the bimolecular model to obtain the foundation of the unique effect of pyrrole aphid ketone, for this compounds later on synthetic provides technical support.
Description of drawings
The 4-that Fig. 1 provides for the utility model preferred embodiments [(3-methylene pyridine)-amino]-6-methyl-4, the chemical model synoptic diagram of 5-dihydro-2H-[1,2,4] triazole-3-ketone.
Fig. 2 is 4-[(3-methylene pyridine)-amino]-6-methyl-4, the schematic arrangement of 5-dihydro-2H-[1,2,4] triazole-3-ketone.
Symbol description
Embodiment
For the purpose, technical scheme and the advantage that make the utility model is clearer,, the utility model is further elaborated below in conjunction with accompanying drawing and embodiment.Should be appreciated that specific embodiment described herein only in order to explanation the utility model, and be not used in qualification the utility model.
Please consult Fig. 1 and Fig. 2 in the lump, the 4-that the utility model preferred embodiments provides [(3-methylene pyridine)-amino]-6-methyl-4,5-dihydro-2H-[1; 2,4] chemical model of triazole-3-ketone, its model for making up according to pyrrole aphid ketone molecular structure; Pyrrole aphid ketone is 4-[(3-methylene pyridine)-amino]-6-methyl-4; 5-dihydro-2H-[1,2,4] triazole-3-ketone.
Some connecting links 20 (as shown in Figure 1) that the chemical model of said pyrrole aphid ketone comprises some spheroids 10 of representing atom and represents chemical bond, two ends 21 of connecting link 20 can be inserted in the spheroid 10, from composition model.Wherein, The chemical model of said pyrrole aphid ketone is made up of two molecules of pyrrole aphid ketone; The chemical model that is said pyrrole aphid ketone comprises two parts; Each part all is an independently pyrrole aphid ketone molecular structure (as shown in Figure 2), and on behalf of the bimolecular weak bond, two-part link connect through one in said some connecting links.
Compared with prior art; The 4-that the utility model provides [(3-methylene pyridine)-amino]-6-methyl-4,5-dihydro-2H-[1,2; 4] chemical model of triazole-3-ketone; Two molecules by pyrrole aphid ketone constitute, and each part all is an independently pyrrole aphid ketone molecular structure, link two-part connecting link and have represented the lone pair electrons of pyridine and the hydrogen bond between the hydrogen atom on the nitrogen-atoms on the triazine ring on the pyridine ring; This hydrogen bond action makes that pyrrole aphid ketone molecule is more stable; It specifically is how to bring into play drug effect in vivo that such chemical model is more conducive to disclose pyrrole aphid ketone, and intermolecular force is the object that our emphasis is considered, the molecular structure under bimolecular and even the polymolecular weak key action is only the key that pyrrole aphid ketone can be brought into play unique drug effect; Utilize the bimolecular model to obtain the foundation of the unique effect of pyrrole aphid ketone, for this compounds later on synthetic provides technical support.
4-[(3-methylene pyridine)-amino]-6-methyl-4, the chemical model of 5-dihydro-2H-[1,2,4] triazole-3-ketone is the bimolecular model, structural rigidity is little, can explain the true rock-steady structure of pyrrole aphid ketone.
The above is merely the preferred embodiment of the utility model; Not in order to restriction the utility model; Any modification of being done within all spirit and principles at the utility model, be equal to replacement and improvement etc., all should be included within the protection domain of the utility model.
Claims (1)
- [1.4-(3-methylene pyridine)-amino]-6-methyl-4; The chemical model of 5-dihydro-2H-[1,2,4] triazole-3-ketone; Its model for making up according to pyrrole aphid ketone molecular structure; The chemical model of said pyrrole aphid ketone comprises some spheroids of representing atom and some connecting links of representing chemical bond, it is characterized in that: the chemical model of said pyrrole aphid ketone is made up of two molecules of pyrrole aphid ketone, and the chemical model of promptly said pyrrole aphid ketone comprises two parts; Each part all is an independently pyrrole aphid ketone molecular structure, and on behalf of the bimolecular weak bond, two-part link connect through one in said some connecting links.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2011205566915U CN202434108U (en) | 2011-12-28 | 2011-12-28 | Chemical model of 4-((3-methylene pyridine)-amino)-6-methyl-4, 5-dihydro-2H-(1, 2, 4) triazole-3-ketone |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2011205566915U CN202434108U (en) | 2011-12-28 | 2011-12-28 | Chemical model of 4-((3-methylene pyridine)-amino)-6-methyl-4, 5-dihydro-2H-(1, 2, 4) triazole-3-ketone |
Publications (1)
Publication Number | Publication Date |
---|---|
CN202434108U true CN202434108U (en) | 2012-09-12 |
Family
ID=46783536
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2011205566915U Expired - Fee Related CN202434108U (en) | 2011-12-28 | 2011-12-28 | Chemical model of 4-((3-methylene pyridine)-amino)-6-methyl-4, 5-dihydro-2H-(1, 2, 4) triazole-3-ketone |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN202434108U (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108623847A (en) * | 2018-06-09 | 2018-10-09 | 郭耀普 | A kind of preparation method of model for model molecule |
-
2011
- 2011-12-28 CN CN2011205566915U patent/CN202434108U/en not_active Expired - Fee Related
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108623847A (en) * | 2018-06-09 | 2018-10-09 | 郭耀普 | A kind of preparation method of model for model molecule |
CN108623847B (en) * | 2018-06-09 | 2020-02-07 | 郭耀普 | Preparation method of model for simulating molecules |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Wendell et al. | Artificial photosynthesis in ranaspumin-2 based foam | |
Ivanov et al. | Recent advances in enzymatic fuel cells: experiments and modeling | |
EP1970984A4 (en) | Catalyst for fuel cell electrode, process for producing catalyst for fuel cell electrode, film-electrode assembly, and fuel cell | |
Cai et al. | Interconversions between uranium mono-metallofullerenes: mechanistic implications and role of asymmetric cages | |
CN202434108U (en) | Chemical model of 4-((3-methylene pyridine)-amino)-6-methyl-4, 5-dihydro-2H-(1, 2, 4) triazole-3-ketone | |
Zhang et al. | Facile, sustainable, and chemical-additive-free synthesis of monodisperse carbon spheres assisted by external pressure | |
Cui et al. | Tissue engineering in urethral reconstruction. | |
Catal et al. | Utilization of mixed monosaccharides for power generation in microbial fuel cells | |
Kim et al. | Artificial photosynthetic biohybrids for CO2 and N2 fixation | |
Ogata et al. | Expression of vascular endothelial growth factor, fibroblast growth factor, and lactate dehydrogenase by human peritoneal mesothelial cells in solutions with lactate or bicarbonate or both. | |
CN201751494U (en) | Simple bathing room | |
Li et al. | One-Step Purification and Immobilization of Glycosyltransferase with Zn–Ni MOF for the Synthesis of Rare Ginsenoside Rh2 | |
CN103054371A (en) | Folding chair | |
Liu et al. | Silk Materials Light Up the Green Society | |
Padams et al. | Fair and the planetary data system | |
CN203088247U (en) | Folding chair | |
Gunasekaran | Physiological studies on Phymatotrichum omnivorum. IX. Synthesis of indole acetic acid in vitro. | |
CN201310294Y (en) | Multifunctional folding ladder | |
Menduti | Boraheterohelicenes: synthetic methodologies and properties of a novel class of boron π-conjugated systems | |
Çalışkan et al. | SELENOPHENE BASED BENZODITHIOPHENE AND QUINOXALINE CONTAINING ALTERNATING CONJUGATED POLYMERS FOR ORGANİC SOLAR CELL | |
CN205601060U (en) | Cerini dialyser cerini silica gel circle mould | |
Cicco et al. | Deep Eutectic Solvents as Non-innocent and Environmentally Responsible Reaction Media for the Divergent Synthesis of Valuable N-Heterocycles from Azides | |
Zhou | Studies on the hydrogen production from hyacinth fermentation | |
Choi et al. | Fabrication of counter electrodes using surface modified carbon nanotubes for dye-sensitized solar cells and their performances | |
Zang | Experimental Visualization of Singlet and Triplet Photovoltaic Processes in Organic Solar Cells |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120912 Termination date: 20151228 |
|
EXPY | Termination of patent right or utility model |